FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Formelli, F.
Right arrow Articles by Olson, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Formelli, F.
Right arrow Articles by Olson, J. A.

The FASEB Journal, Vol 10, 1014-1024, Copyright © 1996 by The Federation of American Societies for Experimental Biology

REVIEWS

Bioactivities of N-(4-hydroxyphenyl) retinamide and retinoyl beta- glucuronide

F Formelli, AB Barua and JA Olson
Istituto Nazionale per lo Studio e la Cura dei Tumori, Division of Experimental Oncology, Milan, Italy.

N-(4-Hydroxyphenyl) retinamide (4HPR) and retinoyl beta-glucuronide (RAG) are two derivatives of all-trans retinoic acid (RA) that show properties both similar to as well as different from their parent compound, RA. Both retinoids possess the important property of showing much-reduced toxicity relative to RA while maintaining significant biological activity. 4HPR, a synthetic derivative, is active in the prevention and treatment of a variety of neoplasms in animals, and by inducing apoptosis, shows growth inhibitory activity against many human tumor cell types in vitro. In humans, 4HPR reduces the incidence of new occurrences of leukoplakia and is currently being tested as a preventive agent for breast cancer. RAG, a naturally occurring metabolite of RA, effectively stimulates the growth of vitamin A- deficient animals, induces the differentiation of epithelial cells in vivo and in vitro, and is effective in the topical treatment of acne in humans. Unlike RA, RAG is nontoxic when applied to the skin and is nonteratogenic when given orally to rats. Possible mechanisms of action of both compounds are discussed. These two derivatives of retinoids show interesting physiologic effects and potentially beneficial pharmacologic actions.


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
V. Appierto, P. Tiberio, M. G. Villani, E. Cavadini, and F. Formelli
PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation
Carcinogenesis, May 1, 2009; 30(5): 824 - 831.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
N. Colombo, F. Formelli, M. G. Cantu, G. Parma, M. Gasco, A. Argusti, A. Santinelli, R. Montironi, E. Cavadini, L. Baglietto, et al.
A Phase I-II Preoperative Biomarker Trial of Fenretinide in Ascitic Ovarian Cancer.
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1914 - 1919.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. G. Villani, V. Appierto, E. Cavadini, A. Bettiga, A. Prinetti, M. Clagett-Dame, R. W. Curley, and F. Formelli
4-Oxo-Fenretinide, a Recently Identified Fenretinide Metabolite, Induces Marked G2-M Cell Cycle Arrest and Apoptosis in Fenretinide-Sensitive and Fenretinide-Resistant Cell Lines.
Cancer Res., March 15, 2006; 66(6): 3238 - 3247.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. M. Simile, G. Pagnan, F. Pastorino, C. Brignole, M. R. De Miglio, M. R. Muroni, G. Asara, M. Frau, M. A. Seddaiu, D. F. Calvisi, et al.
Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-{kappa}B and Mat1A genes in the early stages of rat liver carcinogenesis
Carcinogenesis, February 1, 2005; 26(2): 417 - 427.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. G. Villani, V. Appierto, E. Cavadini, M. Valsecchi, S. Sonnino, R. W. Curley, and F. Formelli
Identification of the Fenretinide Metabolite 4-Oxo-Fenretinide Present in Human Plasma and Formed in Human Ovarian Carcinoma Cells through Induction of Cytochrome P450 26A1
Clin. Cancer Res., September 15, 2004; 10(18): 6265 - 6275.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
A. C. Ross and R. Zolfaghari
Regulation of Hepatic Retinol Metabolism: Perspectives from Studies on Vitamin A Status
J. Nutr., January 1, 2004; 134(1): 269S - 275.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Garaventa, R. Luksch, M. S. L. Piccolo, E. Cavadini, P. G. Montaldo, M. R. Pizzitola, L. Boni, M. Ponzoni, A. Decensi, B. D. Bernardi, et al.
Phase I Trial and Pharmacokinetics of Fenretinide in Children with Neuroblastoma
Clin. Cancer Res., June 1, 2003; 9(6): 2032 - 2039.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Prinetti, L. Basso, V. Appierto, M. G. Villani, M. Valsecchi, N. Loberto, S. Prioni, V. Chigorno, E. Cavadini, F. Formelli, et al.
Altered Sphingolipid Metabolism in N-(4-Hydroxyphenyl)- retinamide-resistant A2780 Human Ovarian Carcinoma Cells
J. Biol. Chem., February 14, 2003; 278(8): 5574 - 5583.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
F. Formelli, T. Camerini, E. Cavadini, V. Appierto, M. G. Villani, A. Costa, G. De Palo, M. G. Di Mauro, and U. Veronesi
Fenretinide Breast Cancer Prevention Trial: Drug and Retinol Plasma Levels in Relation to Age and Disease Outcome
Cancer Epidemiol. Biomarkers Prev., January 1, 2003; 12(1): 34 - 41.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
C. Zou, A.-T. Vlastos, L. Yang, J. Wang, M. Brewer, and M. Follen
Effect of 4-Hydroxyphenylretinamide on Human Cervical Epithelial and Cancer Cell Lines
Reproductive Sciences, January 1, 2003; 10(1): 41 - 48.
[Abstract] [PDF]

Home page
 Am. J. Pathol.Home page
S. A. Gestl, M. D. Green, D. A. Shearer, E. Frauenhoffer, T. R. Tephly, and J. Weisz
Expression of UGT2B7, a UDP-Glucuronosyltransferase Implicated in the Metabolism of 4-Hydroxyestrone and All-Trans Retinoic Acid, in Normal Human Breast Parenchyma and in Invasive and in Situ Breast Cancers
Am. J. Pathol., April 1, 2002; 160(4): 1467 - 1479.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Bruno, C. Tenca, D. Saverino, E. Ciccone, and C. E. Grossi
Apoptosis of squamous cells at different stages of carcinogenesis following 4-HPR treatment
Carcinogenesis, March 1, 2002; 23(3): 447 - 456.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K.-R. You, J. Wen, S.-T. Lee, and D.-G. Kim
Cytochrome c Oxidase Subunit III. A MOLECULAR MARKER FOR N-(4-HYDROXYPHENYL)RETINAMIDE-INDUCED OXIDATIVE STRESS IN HEPATOMA CELLS
J. Biol. Chem., February 1, 2002; 277(6): 3870 - 3877.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Hail Jr. and R. Lotan
Mitochondrial Respiration Is Uniquely Associated with the Prooxidant and Apoptotic Effects of N-(4-Hydroxyphenyl)retinamide
J. Biol. Chem., November 30, 2001; 276(49): 45614 - 45621.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Follen, E. N. Atkinson, D. Schottenfeld, A. Malpica, L. West, S. Lippman, C. Zou, W. N. Hittelman, R. Lotan, and W. K. Hong
A Randomized Clinical Trial of 4-Hydroxyphenylretinamide for High-Grade Squamous Intraepithelial Lesions of the Cervix
Clin. Cancer Res., November 1, 2001; 7(11): 3356 - 3365.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
G. R. Benoit, M. Flexor, F. Besancon, L. Altucci, A. Rossin, J. Hillion, Z. Balajthy, L. Legres, E. Segal-Bendirdjian, H. Gronemeyer, et al.
Autonomous Rexinoid Death Signaling Is Suppressed by Converging Signaling Pathways in Immature Leukemia Cells
Mol. Endocrinol., July 1, 2001; 15(7): 1154 - 1169.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S.-Y. Sun, P. Yue, G. J. Kelloff, V. E. Steele, S. M. Lippman, W. K. Hong, and R. Lotan
Identification of Retinamides That Are More Potent than N-(4-Hydroxyphenyl)retinamide in Inhibiting Growth and Inducing Apoptosis of Human Head and Neck and Lung Cancer Cells
Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 595 - 601.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
N. Hail Jr. and R. Lotan
Mitochondrial Permeability Transition Is a Central Coordinating Event in N-(4-Hydroxyphenyl)retinamide-induced Apoptosis
Cancer Epidemiol. Biomarkers Prev., December 1, 2000; 9(12): 1293 - 1301.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
J. M. Kurie, J. S. Lee, F. R. Khuri, L. Mao, R. C. Morice, J. J. Lee, G. L. Walsh, A. Broxson, S. M. Lippman, J. Y. Ro, et al.
N-(4-Hydroxyphenyl)Retinamide in the Chemoprevention of Squamous Metaplasia and Dysplasia of the Bronchial Epithelium
Clin. Cancer Res., August 1, 2000; 6(8): 2973 - 2979.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
K. C. Lewis and J. F. Hochadel
Retinoid Metabolism in the Prostate: Effects of Administration of the Synthetic Retinoid N-(4-Hydroxyphenyl)retinamide
Cancer Res., December 1, 1999; 59(23): 5947 - 5955.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Chen, J. Buck, and F. Derguini
Anhydroretinol Induces Oxidative Stress and Cell Death
Cancer Res., August 1, 1999; 59(16): 3985 - 3990.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. L. Clifford, D. G. Menter, M. Wang, R. Lotan, and S. M. Lippman
Retinoid Receptor-dependent and -independent Effects of N-(4-Hydroxyphenyl)retinamide in F9 Embryonal Carcinoma Cells
Cancer Res., January 1, 1999; 59(1): 14 - 18.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Goyette, C. Feng Chen, W. Wang, F. Seguin, and D. Lohnes
Characterization of Retinoic Acid Receptor-deficient Keratinocytes
J. Biol. Chem., May 26, 2000; 275(22): 16497 - 16505.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by The Federation of American Societies for Experimental Biology.